Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family

Zobrazit další vydání (1)

Benzodiazepines are psychoactive drugs with anxiolytic, sedative, skeletal muscle relaxant and amnestic properties. Recently triazolo-benzodiazepines have been also described as potent and highly selective protein interaction inhibitors of bromodomain and extra-terminal (BET) proteins, a family of t...

Podrobná bibliografie
Hlavní autoři:	Filippakopoulos, P, Picaud, S, Fedorov, O, Keller, M, Wrobel, M, Morgenstern, O, Bracher, F, Knapp, S
Médium:	Journal article
Jazyk:	English
Vydáno:	2012

Podobné jednotky

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
Autor: Filippakopoulos, P, a další
Vydáno: (2012)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
Autor: Hay, D, a další
Vydáno: (2013)

Chemical probes for bromodomains outside the BET family
Autor: Brennan, P, a další
Vydáno: (2013)

Developing chemical probes for the BET bromodomains
Autor: Hewings, D, a další
Vydáno: (2012)

PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.
Autor: Picaud, S, a další
Vydáno: (2013)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.
Autor: Picaud, S, a další
Vydáno: (2013)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
Autor: Picaud, S, a další
Vydáno: (2013)

Selective inhibition of BET bromodomains.
Autor: Filippakopoulos, P, a další
Vydáno: (2010)

Selective inhibition of BET bromodomains.
Autor: Filippakopoulos, P, a další
Vydáno: (2010)

Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding.
Autor: Kempen, H, a další
Vydáno: (2013)

Discovery of BET bromodomain inhibitors and their role in target validation
Autor: Mueller, S, a další
Vydáno: (2014)

Synthesis and biological investigation of (+)-JD1, an organometallic BET bromodomain inhibitor
Autor: Hassell-Hart, S, a další
Vydáno: (2019)

Interactome rewiring following pharmacological targeting of BET bromodomains
Autor: Lambert, J-P, a další
Vydáno: (2018)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
Autor: Philpott, M, a další
Vydáno: (2011)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
Autor: Philpott, M, a další
Vydáno: (2011)

Chemical probes and inhibitors of bromodomains outside the BET family
Autor: Moustakim, M, a další
Vydáno: (2016)

Evaluation of linker length effects on a BET bromodomain probe
Autor: Traquete, R, a další
Vydáno: (2019)

Promiscuous targeting of bromodomains by Bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
Autor: Picaud, S, a další
Vydáno: (2016)

Bromodomains as therapeutic targets.
Autor: Muller, S, a další
Vydáno: (2011)

Small-molecule bromodomain inhibitors for cancer therapy
Autor: Qi, J, a další
Vydáno: (2010)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
Autor: Ciceri, P, a další
Vydáno: (2014)

Targeting bromodomains: epigenetic readers of lysine acetylation.
Autor: Filippakopoulos, P, a další
Vydáno: (2014)

Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Autor: Cheng, Z, a další
Vydáno: (2013)

Inhibition of BET bromodomain targets genetically diverse glioblastoma.
Autor: Cheng, Z, a další
Vydáno: (2013)

Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
Autor: Ciceri, P, a další
Vydáno: (2014)

Effect of BET missense mutations on bromodomain function, inhibitor binding and stability
Autor: Lori, L, a další
Vydáno: (2016)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
Autor: Popp, T, a další
Vydáno: (2016)

Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability.
Autor: Laura Lori, a další
Vydáno: (2016-01-01)

BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability
Autor: Jennings, L, a další
Vydáno: (2018)

[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
Autor: Fedorov, O, a další
Vydáno: (2014)

The bromodomain interaction module.
Autor: Filippakopoulos, P, a další
Vydáno: (2012)

The bromodomain interaction module
Autor: Filippakopoulos, P, a další
Vydáno: (2012)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
Autor: Rooney, T, a další
Vydáno: (2012)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
Autor: Hewings, D, a další
Vydáno: (2011)

Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
Autor: Chaidos, A, a další
Vydáno: (2014)

Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog pathway inhibitor-1
Autor: Meropi Bagka, a další
Vydáno: (2023-07-01)

3,5-Dimethylisoxazoles inhibit the bromodomain-histone protein-protein interaction
Autor: Hewings, D, a další
Vydáno: (2012)

Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
Autor: Alison M. Kurimchak, a další
Vydáno: (2016-08-01)

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
Autor: Kenneth K. W. To, a další
Vydáno: (2023-03-01)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
Autor: Hewings, D, a další
Vydáno: (2011)